Kontroversi seputer vaksin nampaknya tidak akan pernah reda, baru-baru ini muncul pernyataan Menkes Siti Fadilah Supari “Stop Vaksin Asing“.
Alih-alih membuat tenang kontroversi yang selama ini terus bergulir, justru telah membuat resah sebagian orang tua yang memang memahami risk and benefit dari vaksin tersebut, sama seperti ketika mengeluarkan pernyataan tentang puyer.
Entah mengapa Ibu Menkes ini seakan anti asing banged, lihat polemik namru 2 dan vaksin Avian Influenza(AI).
Ternyata kalau kita mau sedikit menggali informasi, pernyataan Bu Menkes tidak konsisten sama halnya dengan pejabat negeri ini yang lain.
Diberbagi media Menkes menolak campur tangan asing untuk terkait sample H5N1 pada virus Avain Infleunza, nyatanya berita terbaru yang dirilis Tempo,06Mar09
Indonesia bekerja sama dengan Amerika Serikat dan Singapura menjalankan “Proyek Tangerang” untuk penanggulangan flu burung selama 3 tahun dengan nilai
proyek Rp 44 miliar. Kata Simanjuntak Gindo (Kepala Sekretariat Pengendalian Pilot Proyek Pengendalian Flu Burung dan Kesiapsiagaan Menghadapi Pandemi Influenza Depkes)
Sementara issue lain terkait pernyataan-pernyataan Menkes yang selalu mempolitisasi masalah-masalah kesehatan, di rilis Suara Pembaruan-02Feb09.
Gerilya Politik Menkes
[JAKARTA] Menteri Kesehatan Siti Fadilah Supari belakangan diduga menggalang dana politik yang diperoleh dari sejumlah praktik korupsi, kolusi, dan nepotisme (KKN) di Departemen Kesehatan. Dana politik tersebut digunakan untuk kepentingan politik tertentu, baik secara pribadi maupun disalurkan kepada partai politik guna menghadapi pemilihan umum (Pemilu) legislatif dan pemilihan presiden (Pilpres) tahun ini. Informasi seputar gerilya politik tersebut
sebenarnya sudah dilakukan sejak pertengahan 2008 yang diduga terkait dengan sejumlah proyek bermasalah di lingkungan departemen tersebut.
“Sejak pertengahan 2008 lalu, aktivitas politik yang dilakukan oleh Menteri Kesehatan tersebut untuk menggalang dukungan agar tetap menjabat pada periode pemerintahan mendatang,” ungkap sumber SP.
Sebuah media mingguan edisi Juli 2008 membuat laporan khusus terkait langkah politik menteri yang merupakan ” titipan” mantan Ketua Umum PP Muhammadiyah Ahmad Syafii Maarif dalam Kabinet Indonesia Bersatu ini.
Siti melakukan sejumlah lobi politik untuk menyukseskan Susilo Bambang Yudhoyono kembali terpilih kembali sebagai presiden melalui dukungan finansial kepada sebuah partai. Untuk memuluskan gerakan politik tersebut maka dilakukan penggelembungan sejumlah anggaran proyek. Penelusuran yang dilakukan
Pusat Studi Kebijakan Pembangunan Kesehatan Masyarakat (Puskeb-PKM) menyebutkan, beberapa proyek tersebut seperti dana penanggulangan busung lapar/gizi buruk 2005 dengan kerugian negara mencapai Rp 14,89 miliar; pengadaan peralatan penanganan flu burung pada 2006 dengan anggaran sekitar Rp 40,66 miliar; pengadaan alat rontgen portable untuk Puskesmas di daerah tertinggal, terpencil, dan perbatasan untuk 2007.
Dugaan KKN tersebut semakin menguat dengan pergantian Sekretaris Direktorat Jenderal Bina Pelayanan Medik sebanyak enam kali. Direktorat ini menangani sebagian besar megaproyek dan untuk menutupi praktik KKN tersebut maka dilakukan pergantian sekretaris dalam waktu yang sangat cepat.
Dijelaskan juga, penyimpangan lain yang dilakukan adalah pemborosan anggaran melalui iklan-iklan Departemen Kesehatan. Informasi lain juga menyebutkan anggaran untuk proyek iklan dan pencitraan tersebut menghabiskan dana lebih dari Rp 500 miliar.
“Banyak anggaran yang dihabiskan tanpa mengutamakan pesan-pesan yang ingin disampaikan kepada masyarakat. Sebaliknya, penonjolan justru dilakukan terhadap figur Menteri Kesehatan,” kata sumber itu.
Kontrovesi lain mencuat pada Oktober 2008 sehubungan pemusnahan produk makanan dan minuman bermelamin di kantor Badan Pengawasan Obat dan Makanan. Ketegangan justru terjadi antara Wakil Presiden Jusuf Kalla dan Siti Fadilah Supari yang diduga karena tarik-menarik kepentingan antarberbagai pihak. [H-12]
Last modified: 2/2/09
Terlepas dari hal tersebut, tanggapan saya perihal STOP Vaksin Asing.
Saya memahami maksud pernyataan beliau tentang penyetopan peredaran vaksin diluar yang wajib, namun mbok yah sebelum mengeluarkan statment itu dikaji lebih dulu, apa susahnya untuk memanggil IDAI dalam hal ini yang telah merekomendasikan berbagi macam vaksin untuk anak-anak yang dianjurkan yang beredar di tengah-tengah masyarakat.
Tentu tidak sembarangan IDAI lewat Satgas Imunisasi IDAI merekomendasikan hal itu, meskipun ada beberapa catatan dari saya terkait dengan rekomendasi vaksin-vaksin yang di anjurkan yang harganya selangit itu.
Kalau memang niat Menkes adalah untuk mengurangi ketergantungan pada vaksin produksi luar negeri itu sih sah-sah saja, bahkan lebih bagus lagi mendorong BUMN dalam hal ini Biofarma untuk mampu membuat vaksin yang dianjurkan tersebut, jadi bukan hanya vaksin wajib saja yang dibuatnya, tentu ini akan menekan ongkos produksi dan lain-lain.
Terlebih bisnis vaksin ini sangat luar biasa sekali, menurut survey yang dilakukan United Press International (UPI) tahun 2007 sudah mencapai US$10Billion dan tahun 2012 diperkirakan meningkat menjadi US$23.8Billion.
Sementara issue yang lain terkait bisnis vaksin ini juga pernah merebak di media massa Amerika, terkait persetujuan FDA terhadap vaksin Rotavirus 31 Maret 1998 yang dapat menyebabkan “intussuception” (sumbatan usus besar) yang telah ditemukan 99 kasus yang dapat menyebabkan kematian, sehingga November 1999 vaksin ini ditarik dari peredaran.
Baru akhir tahun 2006 FDA menyetujui vaksin Rotavirus generasi kedua :RotaTeq dan Rotarix yang sampai saat ini belum ditemukan kasus serupa.
Apa yang telah terjadi dibalik itu adalah bagian dari konflik kepentingan, baik itu FDA maupun CDC, ini yg pernah di ungkap Burton sebagai Ketua Komite Reformasi untuk pemerintah selaku anggota DPR.
Bahwa beberapa anggota FDA dan CDC memiliki saham di perusahaan pembuat vaksin dan beberapa dari mereka juga mempunyai hak paten, salah satunya Paul Offit M.D yg mempunyai hak paten atas vaksin Rotavirus, sementara John Modlin dari CDC juga merangkap jabatan sebagai salah satu dewan penasehat MERCK (perusahaan pembuat vaksin) dan mempunyai saham US$26.000.
Mungkin inilah yang Kita juga harus lebih hati-hati, kenapa harga vaksin yang dianjurkan di Indonesia teramat sangat mahal sekali, kalau memang benefitnya lebih banyak kenapa juga pemerintah tidak mensubsidinya.
Bukankah sudah begitu jelas tujuan pemberian vaksin dalam jangka pendek adalah mengurangi angka kesakitan/ angka kematian, tujuan jangka panjang adalag eradikasi penyakit infeksi dan tujuan filosofisnya adalah mencegah human suffering.
Ada 2 jenis vaksin rekomendasi IDAI 2007 :
1. Diwajibkan : BCG, Hep-B, Polio, DPT dan Campak
2. Dianjurkan : HIB, Pneumokokus(PCV/IPD), Influenza, MMR, Tifoid, Hep A dan Varisela
Jadual dapat didownload disini
Kontroversi Seputar Vaksin
Sampai saat ini ada beberapa kontroversi seputar vaksin baik yang menyangkut kontroversi seputar kehalalan
ataupun kontroversi seputar autis.
Sementara kontroversi seputar riks and benefit terkait dengan vaksin yang dianjurkan adalah : vaksin Pnemuokokus(PCV/IPD) dan Influenza.
# Vaksin Influenza
Imunisasi influenza ditujukan untuk mencegah penyakit yang disebabkan oleh virus influenza, bukan common cold biasa yang sekedar butuh istirahat yang cukup dan asupan makanan yang baik atau dengan terapi decongestan, namun sebaliknya sedikit yang saya ketahui kalau flu akibat virus influenza tidak cukup dengan hal seperti itu atau decongestan…karena gejala klinisnya lebih parah lagi : nyeri tulang, nyeri perut hebat, demam tinggi dan terkadang disertai muntah-muntah. Imunisasi Influenza tidak bisa mencegah infeksi virus lain atau bakteri yang juga bisa menyebabkan infeksi saluran napas akut.
Imunisasi influenza lebih dianjurkan untuk anak yang berisiko tinggi menjadi fatal kalo kena virus ini, misalnya anak dengan gangguan sistem kekebalan, anak dengan keganasan, anak yg minum steroid jangka panjang dll.
Point penting :
a. Belum ada data penelitiannya sehingga efektifitasnya belum diketahui secara pasti
b. Antigen virus ini sangat tidak stabil, strainya mudah berubah-ubah sehingga setiap tahun harus ganti.
c. Harganya sangat mahal
Annual vaccination against influenza is recommended for:
1. Summary of influenza vaccination recommendations, 2008: children and adolescents aged 6 months–18 years
Vaccination of all children aged 6 months–18 years should begin before or during the 2008–09 influenza season if feasible, but no later than during the 2009–10 influenza season. Vaccination of all children aged 5–18 years is a new ACIP recommendation.
Children and adolescents at high risk for influenza complications should continue to be a focus of vaccination efforts as providers and programs transition to routinely vaccinating all children and adolescents. Recommendations for these children have not changed. Children and adolescents at higher risk for influenza
complication are those:
* aged 6 months–4 years;
* who have chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, hematological or metabolic disorders (including diabetes mellitus);
* who are immunosuppressed (including immunosuppression caused by medications or by human immunodeficiency virus);
* who have any condition (e.g., cognitive dysfunction, spinal cord injuries, seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk for aspiration;
* who are receiving long-term aspirin therapy who therefore might be at risk for experiencing Reye syndrome after influenza virus infection;
* who are residents of chronic-care facilities; and,
* who will be pregnant during the influenza season.
Note: Children aged <6 months should not receive influenza vaccination. Household and other close contacts (e.g., daycare providers) of children aged <6 months, including older children and adolescents, should be vaccinated.
2. Summary of influenza vaccination recommendations, 2008: adults
Annual recommendations for adults have not changed. Annual vaccination against influenza is recommended for any adult who wants to reduce the risk for becoming ill with influenza or of transmitting it to others. Vaccination also is recommended for all adults in the following groups, because these persons are either at high risk for influenza complications, or are close contacts of persons at higher risk:
* persons aged >50 years;
* women who will be pregnant during the influenza season;
* persons who have chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, hematological or metabolic disorders (including diabetes mellitus);
* persons who have immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus);
* persons who have any condition (e.g., cognitive dysfunction, spinal cord injuries, seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk for aspiration;
* residents of nursing homes and other chronic-care facilities;
* health-care personnel;
* household contacts and caregivers of children aged <5 years and adults aged >50 years, with particular emphasis on vaccinating contacts of children aged <6 months; and,
* household contacts and caregivers of persons with medical conditions that put them at high risk for severe complications from influenza.
NOTE: The text above is taken from Prevention & Control of Influenza – Recommendations of the Advisory Committee on Immunization Practices (ACIP) 2008.
MMWR 2008 Aug 8; 57(RR07);1-60. (Also available as PDF, 586K).
# Vaksin HPV (Human Papilloma Virus)
Vaksin ini belum masuk rekomendasi IDAI, namun pemberitaan dan iklannya juga sangat luar biasa sekali.
Dikatakan bahwa vaksin HPV ini mampu mencegah terjadinya kanker serviks.
Namun dalam penelusuran saya ada beberapa point penting.
EIGHTEEN DEATHS LINKED TO GARDASIL VACCINE REPORT CLAIMS
By NWV Staff Writer, Sarah Foster
Posted 1:00 AM Eastern
July 17, 2008
A recent publication by a conservative watchdog group has rekindled media interest in a controversial anti-virus vaccine and sent Big Pharma and federal health agency officials into damage control mode.
In a 25-page special report released June 30, Judicial Watch — a Washington DC-based nonprofit organization that promotes “transparency and accountability in government” – presents evidence based on government documents that in the two years since being licensed by the Food and Drug Administration, Merck & Co’s Gardasil, heavily promoted as a safe and effective vaccine against cervical cancer, has been connected with nearly 9,000 “adverse events,” including the deaths of 18 – perhaps 20 – girls and young women.
In addition, there were 140 “serious” events reported (27 categorized as “life-threatening”), with 10 spontaneous abortions and six cases of Guillain-Barre Syndrome – all since January 2008.
Guillain-Barre Syndrome (GBS) is a rare, potentially devastating autoimmune disorder that attacks the peripheral nervous system and can lead to paralysis and, occasionally, death. There is no known cure or cause, but a fact sheet from the National Institute of Health says it’s sometimes triggered by surgery or vaccinations. Judicial Watch uncovered a total of 38 cases of GBS have been filed with the FDA since June 2006 (six since January) among girls who had received at least one dose of the three-dose vaccine.
The records indicate 10 deaths since last September, bringing the total number of Gardasil-connected death reports in the United States to at least 18 – four of these were from blood clots, nine from unknown or unidentifiable causes.
The fatalities include:
A 20-year-old woman with no medical history reported, who was vaccinated April 1, 2008, with Gardasil and died four days later, seeking medical attention. An autopsy was performed which ruled out suicide or anything suspicious. The cause of death is currently unknown. [VAERS ID 310262-1 (D)]
A 12-year-old girl with no reported medical problems, who died in her sleep of known causes on Oct. 6, 2007, three weeks after receiving a Gardasil shot.
[VAERS ID: 297528-1 (D)]
An 11-year-old girl, vaccinated in May 2007 with a first dose of Gardasil, who died three days later after going to an emergency room. A physician at the hospital said “death was due to an anaphylactic [severe allergic] reaction to Gardasil.”[VAERS ID 280163-1 (D)]Because adverse reactions to medication tend to be underreported, Judicial Watch believes the actual number is likely to be higher.
“I think we’ve uncovered a lot of disturbing things about Gardasil,” said Judicial Watch president Tom Fitton. “All we’re asking for is further investigation of its safety. We’re not convinced they’re taking these reports seriously.”
Gardasil is the first vaccine on the market that targets the four strains of sexually transmitted human papillomavirus (HPV) believed to account for most cases of cervical cancer and genital warts infections.
HPV is not contagious in the way tuberculosis or measles or the common cold is. You don’t become HPV-infected by being in a crowd or sitting near someone, but through skin-to-skin contact. There are over 100 strains of HPV, 30 of which are sexually transmitted – and of these 30, 15 can cause cervical lesions and other abnormalities that may develop into cervical cancer, while about 12 can cause genital warts. Two of the strains targeted by Gardasil (HPV 16 and 18) are believed responsible for 70 percent of the cancer cases, the other two (HPV 6 and 11) cause 90 percent of the genital warts infections.
The FDA approved Gardasil on June 8, 2006, for girls and women ages nine to 26. Less than a month later the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommended vaccination for all girls, ages 11 to 12. The committee’s first report on Gardasil was published the following March.
Gardasil was fast-tracked and received FDA approval before testing was complete and its final safety evaluation trials won’t be concluded until Sept. 2009.
Despite this, the drug is being aggressively mass-marketed on TV and at the movies in ads pitched to young girls, including preteens, and state legislators were heavily lobbied to make the drug mandatory for school girls ages 11 up. Sold worldwide, Merck reports over 16 million doses of the vaccine have been distributed in the U.S. , and eight million women and girls have received at least one shot of the three-dose regimen.
The special report – its complete title is Examining the FDA’s HPV Vaccine Records: Detailing the Approval Process, Side-Effects, Safety Concerns and Marketing Practices of a Large-Scale Public Health Experiment — continues work Judicial Watch began in 2007 when it published two analyses (the first in May
of that year, the second in Oct.) of Gardasil-related documents it had received in sets from the FDA, after making requests through the Freedom of Information Act.
As in its earlier reports, the group raises serious questions about the vaccine’s effectiveness, safety, long-range effects and overall costs — which are astronomical. At $120 a shot ($360 for the requisite three-doses), Gardasil is the most expensive vaccine on the market.
The VAERS Reports
Using FOIA, Judicial Watch obtained thousands of pages from the FDA, including 8,864 reports filed by doctors, nurses, parents and others with the Vaccine
Adverse Events Reporting System [VAERS] – a database shared by the CDC and FDA — detailing reactions experienced by girls and women after receiving at least one shot of the vaccine.
Besides the deaths, the VAERS reports reveal a gamut of reactions – from trivial to terrifying — including vomiting, dizziness, seizures, paralysis and Guillain-Barre Syndrome, swelling at the injection site and in lymph nodes in the neck and groin, fevers, hives, shortness of breath, nausea and flu-like symptoms.
There were reports of a sudden appearance of blisters on a 20-year-old’s upper arms and back and ano-genital warts on a 12-year-old. A 15-year-old reported blisters that appeared in her vaginal area within two days of receiving the vaccine and spread to her upper body and behind her ears and knees. These lasted five to seven days, then developed scabs.
Judicial Watch’s use and dissemination of VAERS reports have drawn criticism from the FDA, the CDC, Merck and other advocates of the vaccine, in part because anyone can file a VAERS report — physicians, nurses, family members and patients — so the accounts tend to be dismissed as “anecdotal” and lacking-in-evidence. More important, they don’t prove the vaccine caused the event.
In the wake of the Judicial Watch report, Merck issued a press statement downplaying the findings.
The mega-drug company claimed to have “analyzed the adverse events reported for Gardasil … and based on the data available to Merck, believes that no safety issue related to the vaccine has been identified. … An adverse experience report describes an event that occurred after vaccination and does not necessarily mean that the vaccine caused or contributed to the event. The vast majority of adverse events that have been reported to Merck are non-serious and the most common include dizziness and syncope (fainting).”
In a similar vein, FDA spokeswoman Kelly Riley told the Sydney Morning Herald, an Australian newspaper, that there was nothing in the VAERS reports to cause a review of the usefulness of the vaccine. “These adverse reaction reports have not been analyzed. If there’s a death after someone received a vaccine, and long after they had a car crash, a bee sting … these would be filled out. It does not mean Gardasil caused it.”
The FDA and CDC said that safety data reviewed in approving Gardasil showed only mild side effects, like pain at the injection site or fainting.
But Tegan Millspaw, the report’s lead researcher and principal author, says these critics are missing the point.
“Judicial Watch was not and is not interested in proving causality,” she writes. ”Only science can do that. And that is why we asked for more investigation of the VAERS reports to ensure there was no causality between Gardasil and the serious reported adverse reactions”
There were 18 deaths, she points out – and of those, 11 occurred less than a week after the girl had received the vaccine, seven in less than two days.
“Perhaps all these deaths are simply coincidence, but given the unknowns about Gardasil and its overall safety, it is far too important an issue to simply ignore,” Millspaw states.
Making Bad Symptoms Worse
Attracting less attention from the media are the cases of groin and genital warts – 78 VAERS-reported cases — which weren’t supposed to happen considering that Gardasil is a vaccine against the two strains of HPV that cause 90 percent of such outbreaks. But Gardasil is not a cure, it is a preventative medication – and in some instances it seems to have triggered outbreaks or made existing conditions worse, for there are reports of warts suddenly appearing after vaccination on the face, hands, feet and chest.
“Not only will Gardasil not cure pre-existing HPV, it can also make symptoms worse,” warns Millspaw in the report. “Women who already have the virus without knowing it could suffer massive outbreaks of genital warts or abnormal precancerous lesions, both of which require extensive treatment.”
“The outcomes that can result from pre-exposure are disconcerting and deserve far more attention.” Contacted by telephone, Millspaw told NewsWithViews of her concern that Merck did not screen women prior to vaccination for possible HPV exposure or infection.
“The reason they target very young girls is it’s easier to assume they don’t have the viruses – but the women are not screened to see if they’ve been exposed.
The FDA allows that, which I find very disturbing.”
Asked whether the drug could cause sterility, Millspaw told NewsWithViews there’s “no indication” of this – “but they’re now vaccinating very young girls, so it will be years before long-term effects are known. They haven’t done enough tests to know at this point.”
Millspaw brought up another long-range possibility. “A lot of scientists are worried that preventing these four strains may just cause other HPV viruses to take their place,” she said. “That could be serious, particularly because while the vaccine protects against two main forms of cervical cancer the other  strains are usually more severe.”
“Given all the questions about Gardasil, the best public health policy would be to re-evaluate its safety and to prohibit its distribution to minors,” said Tom Fitton in a press release. “In the least, governments should rethink any efforts to mandate or promote this vaccine for children.” Backlash
Fitton was referring particularly to the action that sparked the most controversy about the vaccine and unleashed a furious backlash against it: Merck’s aggressive lobbying aimed at state legislatures.
The company began marketing the drug even before the FDA gave the green light. Not by name – that would be illegal — but through a sophisticated, high-pressure public relations campaign using TV and Internet ads designed to frighten young girls about cervical cancer and HPV, so that they would accept – and demand – the drug once it became available.
But Merck was not content merely to advertise the vaccine and make it accessible to those who wanted it; as soon as it got the high-sign from the FDA it funded a huge lobbying effort to persuade state lawmakers to mandate Gardasil vaccination of young girls, including preteens, as a condition for attending public or private school.
The campaign has been fairly successful. To date: 41 states have introduced legislation to require, fund or educate the public about the HPV vaccine and 17 enacted legislation. Three considered making vaccination mandatory.
It was too much. Parents and consumer advocates from all points across the political spectrum were outraged, and in Feb. 2007 Merck announced it was dropping its lobbying campaign – though its TV advertising continues. But the lobbying was so intense, many former supporters were inspired to take a closer look at Merck and to question its motives for mass-marketing a drug before it’s been fully tested and evaluated for safety and efficacy.
A ‘Wonder Drug’ for Merck?
For instance, last July Judith Siers-Poisson, editor of PR Watch, authored a devastating four-part series for CounterPunch, a leftist biweekly newsletter, titled “The Politics and PR of Cervical Cancer,” in which she took a hard look at HPV and Gardasil – “the facts, the hype, and what Merck stands to gain, the marketing campaigns … and the media’s lack of attention to concerns about the rush to mandate vaccination…”
“Guardasil is being touted as a “wonder drug” for women. Might it also be a wonder drug for Merck?” Siers-Poisson asked then answered:
“In the world of drugs, vaccines for use by the whole population are close to corporate nirvana since they ensure a mass market for prevention instead of having to wait to identify the smaller number of people who actually develop a particular disease. In addition, mandating vaccination helps ensure a mass market and gets the government involved in what would otherwise be left to market forces.”
The drug could likely go far in replenishing the pockets of the firm as it recovers from the Vioxx recall, in which Merck’s pain medication was held to be responsible for 27,000 heart attacks and sudden cardiac deaths. Analysts estimate that the Vioxx recall decreased Merck’s stock value, and could cost Merck up to $20 billion in legal settlements.
At $360 for the three-shot regimen, Gardasil is the most expensive vaccine the FDA has ever approved. A measles-mumps-rubella combo costs $42.85. The New York Times estimates that making the vaccine mandatory would double the cost of existing vaccine programs. And John Schiller, a senior investigator for the National Institute, told the Times “This vaccine will be more expensive than all childhood vaccines put together.”
But whether paid for by insurance, tax dollars, or individual parents – at $360 a patient Merck is guaranteed billions of dollars.
It’s already paying off. Even without Gardasil being mandated, the incessant campaign has persuaded millions of young women to be vaccinated – and netted Merck $1.5 billion in sales revenue in 2007, according to the Securities and Exchange Commission.
How Serious a Threat?
But how serious a threat is the disease which is already costing millions of dollars to vaccinate against?
Cervical cancer is a major killer of women in non-industrial nations – as it once was in this country. Worldwide it affects 470,000 women and kills 233,000 each year. This is not the case in the United States thanks to widespread Pap screening. This is a medical screening test involving the examination of cells taken from the cervix to detect pre-malignant and malignant cervical cancer cells. It is named after its inventor, Dr. George Papanicolaou, who developed it over 60 years ago.
As a result of routine Pap tests and early, follow-up treatment when necessary, the deaths from cervical cancer plummeted 74 percent between 1955 and 1992, according to the American Cancer Society, and that rate continues downward by about four percent a year.
Today in the United States cervical cancer is so rare that it is not on the National Cancer Institute’s list of 13 most common cancers. To qualify as a common cancer, the estimated annual incidence for 2008 had to be 35,000 cases or more.
Nor is it among the top 10 deadliest diseases for women, which are heart disease and stroke, followed by lung cancer (third place, with 71,030 deaths), breast cancer (6th, with 40,480 deaths) and colon cancer (10th with 25,700 deaths), according to the American Cancer Society.
The American Cancer Society estimates that in 2008, about 11,070 women in the United States will be diagnosed with invasive cervical cancer in the United States and 3,870 women will die from it. The tragedy behind those deaths is that they could likely have been prevented had the women received regular Pap tests and treatment.
Millspaw concludes: “With these statistics in mind, one must ask whether Gardasil vaccination is absolutely necessary, especially for children. At this point in time, we do not know if it will prevent cancer, or whether it will have unforeseen consequences. The American public must ask themselves if Gardasil is really
worth the risk. Fast-tracking drugs and vaccines before their safety has been fully evaluated is unethical and dangerous, and until more tests have been completed on Gardasil no vaccination mandates should be established.” Below is a list from the special report summarizing objections to the vaccine Gardasil has not been tested thoroughly enough to know whether it will be safe or effective in the long term.
Even if it is shown that the Gardasil vaccine is effective, it is still unknown how long the vaccine lasts or if there will be a need for booster shots.
Regardless of its potential to help prevent HPV and cancer, Gardasil should never be administered without a prescreening for HPV since it has the potential to make existing cases worsen.
It is important that people remember that this vaccine will not eliminate the need for regular PAP screening. No vaccine is 100 percent effective, and Gardasil is designed to protect against only four strains of HPV.
While Gardasil may be an important medical advance, it is unwise to compromise the health and safety of the American public, especially children, by mandating or marketing it before sufficient tests are concluded.
Links for Further Reading
1. Judicial Watch has posted its earlier publications, VAERS reports and other documents on its website: http://www.judicialwatch.org/gardasil
2. George F. Sawaya, M.D., and Karen Smith-McCune, M.D., Ph.D: “HPV Vaccination: More Answers, More Questions,” New England Journal of Medicine, May 10, 2007
3. Judith Siers-Poisson: “The Politics and PR of Cervical Cancer”four parts), posted at PR Watch.
4. Cindy Bevington: “Researcher blasts HPV Marketing.” An interview with Diane Harper, Fort Wayne Daily News.
Selected Earlier Stories
1. Devvy Kidd: How Many More Will Die Before FDA Ghouls Are Held Accountable?, July 14, 2007
2. Sherri Tenpenny, M.D.: Reasons to Just Say No to Vaccines, July 9, 2008
3. Devvy Kidd: Treachery and Tragedy, Oct. 8, 2007
4. Sherri Tenpenny, M.D.: Gardasil Dangers Starting to Emerge, May 10, 2007
5. Devvy Kidd: Confirmed: Your Daughter is Merck’s Guinea Pig, March 16, 2007
6. Devvy Kidd: Texas HPV Vaccination: Parents Can Opt Out, Feb. 8, 2007
7. Mary Starrett: Cancer Vaccine for Sexually Active Pre-teens?, July 26, 2006
© 2008 NWV – All Rights Reserved
To summarize some of the facts about HPV and this vaccine:
• HPV vaccine increases the risk of developing a precancerous cervical lesion by 44.6% in women .previously infected with a HPV viral type found in the vaccine.
• HPV virus does not cause cervical cancer.
• HPV viral infections are self limiting and are not a health threat to healthy females.
• This valuable information about the etiology of HPV viral infections has been suppressed from public knowledge.
• Allowing untruths about Gardasil to be disseminated in public hearings and planting fear have been used to promote sales of this worthless vaccine.
The Evidence for the Gardasil Fraud
HiFi DNA Tech was involved in manufacturing a portable device for testing for HPV viral infection. This company, to improve sales, needed to have their product reclassified as Class II instead of Class III because Class III category products are not able to be sold to the public whereas Class II products can be sold to the public because they are deemed safe enough for public release.
For 20 years the FDA had classified the HPV test as a test for cervical cancer. In 2003 the FDA changed its position advising that HPV virus was not associated with cervical cancer. On Oct12, 2007 HiFi DNA Tech sued the FDA to get their testing device reclassified as Class II based on the knowledge that cervical cancer was not caused by HPV infection .and therefore did not need to be restricted from public sales. The fact that the FDA had already acknowledged
in a policy statement on March 31, 2003 that “most infections by HPV are shortlived and not associated with cervical cancer. Most women who become infected with HPV are able to eradicate the virus and suffer no apparent long term consequences to their health.” It is not the HPV virus itself that causes cervical cancer but rather a persistent state of ill health on the part of the patient that makes her vulnerable to cervical cancer. Repeated transient HPV infections even when
caused by high risk types of HPVs are characteristically not associated with an increased risk of developing squamous intraepithelial lesions, the precursor lesion of cervical cancer.
This was not revealed when the public hearings over the need for mandatory HPV vaccinations was pushed by manufacturer of Gardasil. The FDA had known for many years that HPV was unrelated to cervical cancer but to have this knowledge disseminated during the hearings would have instantly made the HPV vaccine worthless.
The main push from the drug company has been that we “must save these young girls from losing their lives to cervical cancers.” The FDA knew when these hearings were held that this argument was phony but said nothing.!!!
Does the HPV Vaccine Actually Increase the Risk of Cervical Cancer?
Gardasil vaccine actually increases the risk for a sexually active woman to develop cervical cancer (nearly all sexually active women have been exposed to HPV virus). Women who have already been exposed to HPV from sexual activity and have positive serologies for HPV viral types found in the HPV vaccine have a 44.6% increased risk  for developing high grade precancerous cervical lesions after they have received Gardasil vaccine injections. This means that young
women carrying a harmless form of HPV viral infection often get converted after HPV vaccine, into a more dangerous precancerous cervical condition. that can lead to cervical cancer.
These patients were made worse by exposure to a vaccine that contained a virus that had already infected them. Thus this evidence reveals that Gardasil increases disease in 44.6 % of patients who already been exposed to the same serotype found in the vaccine. This strongly suggests that sexually active women can become more likely to develop cervical cancer after taking Gardasil vaccine.
This information puts the state of Texas in the position where theoretically the Gardasil should be given only to young females who are virgins (sexually active females have existing HPV infections that may become more dangerous if given the vaccine). Questioning these young women about sexual activity may lead to sexually active girls denying sexual activity in the presence of parents or physician thus leading to HPV viral administration to a female with previous HPV
infection who does have an increased risk of developing pre-invasive cervical lesions because of exposure to the vaccine. Thus females denying sexual activity will have an increased risk of getting pre-cancerous cervical lesions which can lead to cervical cancer.
To make this situation even worse the health officials that will be involved in screening candidates for HPV vaccine are heavily involved in promoting vaccine administration (They almost certainly have no idea the vaccine is worthless and capable of causing precancerous cervical lesions). Therefore the truth about the danger of cervical cancer resulting from the vaccine given to sexually active girls will not be given to these young women. This will probably cause an unnecessary increase in cervical cancer.
The FDA Is A Badly Flawed Agency
The FDA is administered by 12 officials. Three of these 12 persons are automatic appointments given to the pharmaceutical industry. If there ever was a situation where the fox is in charge of the chicken house this is it. It is common knowledge among these 9 selected officials that if they play ball with the drug industry they will be moved up to high paying positions with drug companies for their final working years. Very few appointed officials will have the character, with these temptations placed in front of them, .to make honest decisions. One can be certain that no one who had a healthy skepticism about the pharmaceutical industry would ever get appointed to the FDA.
Sebagai informasi pembanding tentang HPV, saya copy paste postingan dr. Hermin ( Dok maaf….tulisannya saya posting kesini untuk pembelajaran Kita bersama).
Mengenai vaksin HPV, setahun yang lalu salah seorang tim peneliti
yang akhirnya menghasilkan vaksin tersebut datang berkunjung ke
rumah sakit Hasan Sadikin, sekedar kunjungan persahabatan atau
semacamnya, saat ini saya di Bagian Patologi Anatomi RSHS, dan
peneliti tersebut pun mampir ke bagian PA, karena berhubungan
dengan proses bimolekular dll.
Penelitian tersebut telah mengambil responden ribuan orang yang
sebgian diantaranya dalah para wanita Indonesia, mereka mengambil
sampel di Jawa Barat daerah pantai utara dan beberapa tempat
lainnya di Bandung dan sekitarnya. Pada saat itu ada juga
pertanyaan serupa, sejauh mana efektifitas vaksin HPV dan apa
fungsi sebenarnya, dll.
Kesimpulan yang bisa saya ambil anatara lain, bahwa terjadinya
kanker serviks dan ataupun kanker-kanker lainnya sangat
multifaktorial, dan untuk kanker serviks 80% kasus disebabkan
oleh HPV tipe 16 dan 18, dan hasil penelitian tersebut maka
dibuatlah vaksin HPV. KArena multifaktorial, maka HPV tipe 16 dan
18 bukanlah satu-satunya penyebab terjadinya kanker serviks,
namun HPV merupakan vaktor utama terjadinya kanker tersebut.Masa
paparan sejak pertama kali kena infeksi HPV sampai terjadinya
kanker adalah sekitar 8-10 tahunan, dan sama halnya dnegan sifat
vaksin lainnya, bila tubuh kita sudah terjangkit infeksi virus
yang bersangkutan maka vaksin akan berkurang efektifitasnya.
Demikian pula dengan vaksin HPV, bila para wanita tersebut telah
berhubungan dan kemungkinan dari hubungan-hubungan tersebut ada
yang menularkan virus HPV, maka peranan vaksin HPV akan
berkurang, bahkan tidak lagi efektif. Oleh karena itu maka
kebijakan pemerintah Belanda dengan memberikan vaksin gratis bagi
para remaja cukup tepat, dnegan asumsi pada usia tersebut para
remaja wanita tersebut belum pernah berhubungan, dan mengingat
kultur pergaulan di Belanda sangat permisif, maka dikeluarkan
kebijakan tersebut, dengan harapan efektifitas vaksin HPV akan
berkeja optimal, sehingga walopun para remaja tersebut melakukan
seks bebas di kemduian hari, diharapkan angka kejadian kanker
serviks di kemudian hari akan jauh menurun, karena proteksi
Vaksin HPV ini tidak 100% menjamin bahwa bagi yang mendapat
infeksi HPV di kemudian hari setelah mendapatkan vaksin akan
bebas dari kanker serviks, karena seperti saya sebutkan
sebelumnya bahwa terjadinya kanker atau karsinogenesis sangat
kompleks, melibatkan banyak faktor dan gen. Dan efektifitas
maksimal vaksin ini adalah bagi para wanita yang belum pernah
berhubungan atau belum pernah terkena infeksi HPV.
Sayangnya, sepanjang yang saya amati, masih banyak dokter
kebidanan yang menyarankan dengan sangat kepada para pasiennya,
padahal pasiennya itu sudah punya anak, dan usia diatas 35 thn,
padahal setahu saya pasien vaksin HPV masih cukup mahal sekali,
sekitar 4 juta rupiah. WAlaopun pasien tersebut bukan lagi
remaja, namun belum pernah terkena infeksi HPV 16 dan 18,
efektifitas vaksin ini masih optimal. Sepanjang para dokter
tersebut memberikan penjelasan yang memadai seperti tersebut
diatas, sehingga pasien mengerti dan tetap memutuskan untuk di
vaksin HPV, tidak masalah, namun kadang-kadang sang dokter
terlalu singkat memberikan penjelasan sehingga hampir menuju ke
salah kaprah, dalam pemberian vaksin HPV ini. Vaksin ini efektif
bagi para wanita yang belum terkena paparan HPV 16 dan 18, jadi
kalopun tetap mau divaksin, pastikan dulu bahwa kita bebas dari
paparan HPV tersebut, lewat pemeriksaan laboratorium. Dan
peneliti dari Belanda itu pun mengungkapkan dengan gamblang kok,
bahwa mereka tidak menutup mata bahwa dibalik produksi vaksin ini
selain karena faktor pertimbangan meningkatka kualitas kesehatan,
juga faktor ekonomi tetap ada, so,..tetap ada unsur dagang,
semakin banyak deman semakin banyak keuntungan. Maka sangat perlu
bagi kita sebagai konsumen untuk menjadi konsumen yang cerdas,
bisa mennetukan mana yang bisa dibeli dan digunakan dan mana yang
Menkes Stop Vaksin Asing
*JAKARTA -* Menteri Kesehatan Siti Fadilah Supari akan menyetop peredaran
vaksin di luar vaksin wajib yang biasa disuntikan untuk bayi. Yakni, vaksin
campak, polio, TB, dan DPT. Sebab, selain vaksin itu, manfaat untuk
kesehatan belum bisa diketahui. Peredaran vaksin itu dikhawatirkan hanya
sebagai politik perdagangan negara adidaya.
‘’Kita ingin meninjau pemberian vaksin kepada bayi. Yang jelas, vaksin yang
dipakai sejak zaman baheula ada BSG, DPT, polio, dan campak. Tetapi, di
masyarakat beredar banyak sekali vaksin di luar yang diharuskan,’’ terang
Siti Fadilah di gedung Depkes kemarin.
Menkes mengatakan, saat ini vaksin-vaksin itu banyak beredar di perkotaan.
Bahkan, kabarnya, jumlah vaksin yang beredar ada sebelas. Karena itu, Depkes
akan meninjau kembali pemakaian vaksin tersebut. Sebab, vaksin-vaksin itu
Menurut dia, vaksin-vaksin itu diadakan bukan berdasar *evidence
based*layaknya keempat vaksin yang harus diberikan kepada balita.
vaksin itu diedarkan berdasar *evidence* dagang oleh negara-negara
Dia berjanji segera mengoordinasikan persoalan tersebut kepada Ikatan Dokter
Anak Indonesia (IDAI). Tujuannya, mereka tidak menerima penawaran vaksin
oleh pihak asing. ‘’Kita akan adakan koordinasi segera. Sebab, vaksin itu
diedarkan melalui IDAI,’’ imbuhnya. *(kit/oki)*
Link yang terkait ini: